Attitudinal barriers to buprenorphine prescription and former waiver training.

Q3 Medicine Journal of opioid management Pub Date : 2024-07-01 DOI:10.5055/jom.0827
Michael P Gannon, Monique Tello, Sarah Wakeman, Jean-Pierre Charles, Stuart Lipsitz, Lipika Samal
{"title":"Attitudinal barriers to buprenorphine prescription and former waiver training.","authors":"Michael P Gannon, Monique Tello, Sarah Wakeman, Jean-Pierre Charles, Stuart Lipsitz, Lipika Samal","doi":"10.5055/jom.0827","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Opioid use disorder (OUD) can be effectively treated with buprenorphine maintenance. Recent changes in federal policy have removed the requirement for physicians to complete additional training to apply for a Drug Enforcement Administration (DEA) waiver to prescribe buprenorphine. At that time, few primary care providers (PCPs) had completed the training for a DEA waiver to prescribe buprenorphine. Our goal was to identify addressable barriers that may persist despite updates to federal legislation.</p><p><strong>Design: </strong>A 42-item survey was distributed to 662 physicians and nurse practitioners at two academic medical centers with 100 respondents.</p><p><strong>Setting: </strong>The survey was sent via email and administered anonymously through SurveyMonkey.</p><p><strong>Patients and participants: </strong>All participants were PCPs, and all PCPs at the two academic medical centers were eligible to participate.</p><p><strong>Interventions: </strong>PCPs responded to the survey by answering questions online.</p><p><strong>Main outcome measures: </strong>PCPs answered questions regarding previous buprenorphine waiver training status, local OUD prevalence, the effectiveness of OUD treatment modalities, and previous barriers to training.</p><p><strong>Results: </strong>Respondents were compared using descriptive statistics and logistic regression. Of the 100 respondents (response rate: 15 percent), 69 percent had not completed the training. Ninety-nine percent of PCPs agreed that OUD was an issue in their area, 94 percent saw patients with OUD, and 91 percent rated buprenorphine maintenance as a very effective treatment for OUD. Previously waivered and nonwaivered providers did not differ in their responses to these questions. Those who had been waivered were less likely to say they did not see enough patients with OUD to justify training (odds ratio [OR] 0.267, p = 0.005) and were less likely to express concern about allowing patients with OUD into their practice (OR 0.348, p = 0.020) than PCPs who had applied for the DEA waiver.</p><p><strong>Conclusions: </strong>Despite nonwaivered PCPs recognizing OUD's prevalence, they were concerned about allowing patients with OUD into their practice and said there were not enough patients to justify training. This suggests that attitudinal barriers are the most appropriate target for current intervention.</p>","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":"20 4","pages":"339-346"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of opioid management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5055/jom.0827","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Opioid use disorder (OUD) can be effectively treated with buprenorphine maintenance. Recent changes in federal policy have removed the requirement for physicians to complete additional training to apply for a Drug Enforcement Administration (DEA) waiver to prescribe buprenorphine. At that time, few primary care providers (PCPs) had completed the training for a DEA waiver to prescribe buprenorphine. Our goal was to identify addressable barriers that may persist despite updates to federal legislation.

Design: A 42-item survey was distributed to 662 physicians and nurse practitioners at two academic medical centers with 100 respondents.

Setting: The survey was sent via email and administered anonymously through SurveyMonkey.

Patients and participants: All participants were PCPs, and all PCPs at the two academic medical centers were eligible to participate.

Interventions: PCPs responded to the survey by answering questions online.

Main outcome measures: PCPs answered questions regarding previous buprenorphine waiver training status, local OUD prevalence, the effectiveness of OUD treatment modalities, and previous barriers to training.

Results: Respondents were compared using descriptive statistics and logistic regression. Of the 100 respondents (response rate: 15 percent), 69 percent had not completed the training. Ninety-nine percent of PCPs agreed that OUD was an issue in their area, 94 percent saw patients with OUD, and 91 percent rated buprenorphine maintenance as a very effective treatment for OUD. Previously waivered and nonwaivered providers did not differ in their responses to these questions. Those who had been waivered were less likely to say they did not see enough patients with OUD to justify training (odds ratio [OR] 0.267, p = 0.005) and were less likely to express concern about allowing patients with OUD into their practice (OR 0.348, p = 0.020) than PCPs who had applied for the DEA waiver.

Conclusions: Despite nonwaivered PCPs recognizing OUD's prevalence, they were concerned about allowing patients with OUD into their practice and said there were not enough patients to justify training. This suggests that attitudinal barriers are the most appropriate target for current intervention.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
丁丙诺啡处方的态度障碍和前豁免培训。
目的:使用丁丙诺啡维持治疗可以有效治疗阿片类药物使用障碍(OUD)。最近联邦政策的变化取消了医生必须完成额外培训才能申请缉毒局(DEA)豁免才能开丁丙诺啡处方的要求。当时,很少有初级保健提供者 (PCP) 完成了申请 DEA 豁免以开具丁丙诺啡处方的培训。我们的目标是找出在联邦立法更新后仍可能存在的可解决的障碍:设计:向两家学术医疗中心的 662 名医生和执业护士发放了一份包含 42 个项目的调查问卷,共有 100 名受访者:调查通过电子邮件发送,并通过 SurveyMonkey 进行匿名管理:所有参与者均为初级保健医生,两个学术医疗中心的所有初级保健医生均有资格参与:主要结果测量指标:初级保健医生回答的问题涉及以前的丁丙诺啡豁免培训情况、当地 OUD 患病率、OUD 治疗方法的有效性以及以前的培训障碍:采用描述性统计和逻辑回归对受访者进行了比较。在 100 名受访者中(回复率:15%),69% 的人未完成培训。99%的初级保健医生认为 OUD 是他们所在地区的一个问题,94%的初级保健医生看过 OUD 患者,91%的初级保健医生认为丁丙诺啡维持治疗是治疗 OUD 的一种非常有效的方法。曾被豁免和未被豁免的医疗服务提供者对这些问题的回答没有差异。与申请 DEA 豁免的初级保健医生相比,曾被豁免的初级保健医生不太可能说他们没有看到足够的 OUD 患者来证明培训的合理性(几率比 [OR] 0.267,p = 0.005),也不太可能对允许 OUD 患者进入他们的诊所表示担忧(OR 0.348,p = 0.020):结论:尽管未申请豁免的初级保健医生认识到 OUD 的普遍性,但他们对允许 OUD 患者执业表示担忧,并表示没有足够的患者来证明培训的合理性。这表明,态度障碍是当前干预的最合适目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of opioid management
Journal of opioid management Medicine-Anesthesiology and Pain Medicine
CiteScore
1.00
自引率
0.00%
发文量
54
期刊介绍: The Journal of Opioid Management deals with all aspects of opioids. From basic science, pre-clinical, clinical, abuse, compliance and addiction medicine, the journal provides and unbiased forum for researchers and clinicians to explore and manage the complexities of opioid prescription.
期刊最新文献
A pilot study to examine the opioid prescribing practices of medical residents. Buprenorphine: An anesthesia-centric review. Initial dose of tapentadol and concomitant use of duloxetine are associated with delirium occurring after initiation of tapentadol therapy in cancer patients. Insurance coverage and consistent pricing is needed for over-the-counter naloxone. Naloxone coprescribing best practice advisory for patients at high risk for opioid-related adverse events.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1